News

June 2022

• Completion of £1.9bn Pharma Intelligence agreement

  01 June 2022

  Portfolio re-balancing and accelerating shareholder returns

March 2022

• Informa 2021 Full Year Results

  15 March 2022

  Growth in revenues and profits, balance sheet strength and further progress with the 2021-2024 Growth Acceleration Plan II

February 2022

• Informa to divest Pharma Intelligence for £1.9bn and commence share buyback

  10 February 2022

  2021-2024 Growth Acceleration Plan II Update

January 2022

• Board Update

  14 January 2022

  Changes to Directors' Responsibilities

December 2021

• 2021-2024 Growth Acceleration Plan II

  07 December 2021

  New Informa: Accelerated growth and portfolio focus

November 2021

• November 2021 Trading Update & Board Update

  17 November 2021

  Improving revenues, profits and cashflow over 2021-2022

October 2021

• Board Update October 2021

  01 October 2021

  Appointment of Non-Executive Directors

July 2021

• Informa 2021 Half Year Results

  29 July 2021

  Informa reports further strength in its Subscriptions-led businesses and returning confidence across its B2B events portfolio

June 2021

• June 2021 Trading Update

  03 June 2021

  Informa provided an update on trading, to coincide with the Group’s 2021 Annual General Meeting

April 2021

• Market update on Financial Intelligence

  26 April 2021

  Combination of Informa’s FBX business with Novantas